Literature DB >> 23346963

Nurse practitioner prescribing practices: the most frequently prescribed medications.

Thomas Buckley1, Andrew Cashin, Meg Stuart, Graeme Browne, Sandra V Dunn.   

Abstract

AIMS AND
OBJECTIVES: To explore which medications Australian nurse practitioners most frequently prescribe.
BACKGROUND: Although nurse practitioners in Australia have prescriptive authority, little is known about which specific medications nurse practitioners are prescribing and how frequently they do so.
DESIGN: Descriptive electronic survey.
METHODS: A total of 209 nurse practitioners reported current prescribing practices. Medications reported were categorised according to the Australian Medicines Handbook major drug classifications and frequencies presented.
RESULTS: Seventy-eight per cent of respondents reported prescribing medications as part of their Nurse Practitioner practice. In total, participants reported prescribing 234 separate medications from most Australian Medicines Handbook major drug classifications. Medications from the classification anti-infective drugs were most frequently prescribed followed by medications from analgesic, psychotropic, cardiovascular, musculoskeletal, genitourinary and gastrointestinal classifications.
CONCLUSION: The majority of nurse practitioners in Australia prescribe medications in their clinical practice, although the proportion of nurse practitioners prescribing has not changed significantly in the past four years. The medications prescribed are comparable with those most frequently prescribed by all prescribers in Australia and highlight the diversity in scope of practice among nurse practitioners. RELEVANCE TO CLINICAL PRACTICE: Findings highlight the importance of Nurse Practitioner's a capacity to prescribe wide variety of medications, especially in practice areas such acute, primary and emergency care. The unique role nurse practitioners in relation to management of patients with infective processes and patients requiring pain relief is highlighted. Insight into current Nurse Practitioner prescribing trends informs future Nurse Practitioner curricular and future continuing education programmes. Findings give unique insight for future service planning, especially service providers considering introducing nurse practitioners to their service. The finding that nurse practitioners prescribing patterns are similar to other non-nurse practitioner prescribers in Australia highlights the potential for service providers to introduce new models of care that are Nurse Practitioner lead.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23346963     DOI: 10.1111/jocn.12086

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

Review 1.  The necessity and possibility of implementation of nurse prescribing in China: An international perspective.

Authors:  Dong-Lan Ling; Chun-Mei Lyu; Hui Liu; Xiao Xiao; Hong-Jing Yu
Journal:  Int J Nurs Sci       Date:  2017-12-29

2.  Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals.

Authors:  Courtney Ierano; Karin Thursky; Trisha Peel; Arjun Rajkhowa; Caroline Marshall; Darshini Ayton
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

3.  Nurse practitioner work patterns: A cross-sectional study.

Authors:  Grainne Lowe; Kathleen Tori; Natasha Jennings; Dan Schiftan; Andrea Driscoll
Journal:  Nurs Open       Date:  2021-01-12

4.  Increased Accessibility to Primary Healthcare Due to Nurse Prescribing of Medicines.

Authors:  Dorota Kilańska; Anna Lipert; Marika Guzek; Per Engelseth; Michał Marczak; Kamila Sienkiewicz; Remigiusz Kozłowski
Journal:  Int J Environ Res Public Health       Date:  2021-12-28       Impact factor: 3.390

5.  The development of nurse prescribing in mental health services: Outcomes from five national surveys 2004-2019.

Authors:  Neil Brimblecombe; David Dobel-Ober
Journal:  J Nurs Manag       Date:  2022-03-21       Impact factor: 4.680

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.